Inclusion completed

Safety of UV1 vaccination in combination with ipilimumab in patients with unresectable or metastatic malignant melanoma

Cancer type: Melanoma

Phase: I/II

Principal Investigator: Guren Tormod

Country: NO

Keywords: UV1 vaccination, ipilimumab, melanoma, Norway, Oslo

Status: Inclusion completed

Link to Clinicaltrials.gov: http://www.clinicaltrials.gov/ct2/show/NCT02275416?term=UV1+and+ipilimumab&rank=1